174 related articles for article (PubMed ID: 24515446)
21. Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL).
Kavanaugh A; Mease P
J Rheumatol Suppl; 2012 Jul; 89():90-3. PubMed ID: 22751603
[TBL] [Abstract][Full Text] [Related]
22. Assessment of serum levels of anti-cyclic citrullinated peptide antibodies in patients with psoriatic arthritis: A cross-sectional study in a Brazilian cohort.
Gruber C; Skare T; Campos APB; Simioni J; Maestri V; Nisihara R
Biomed Rep; 2020 Nov; 13(5):36. PubMed ID: 32843964
[TBL] [Abstract][Full Text] [Related]
23. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
Nyhäll-Wåhlin BM; Turesson C; Jacobsson LT; Nilsson JÅ; Forslind K; Albertsson K; Rönnelid J; Petersson IF
Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
[TBL] [Abstract][Full Text] [Related]
24. Anti-cyclic citrullinated peptide antibody in psoriatic arthritis: a meta-analysis of its frequency and association with clinical features.
Kim KY; Lee YH
Z Rheumatol; 2020 May; 79(4):397-403. PubMed ID: 31286191
[TBL] [Abstract][Full Text] [Related]
25. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
Popescu C; Zofotă S; Bojincă V; Ionescu R
Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
[TBL] [Abstract][Full Text] [Related]
26. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.
Eder L; Thavaneswaran A; Chandran V; Gladman DD
Ann Rheum Dis; 2014 Jun; 73(6):1007-11. PubMed ID: 23619157
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
[TBL] [Abstract][Full Text] [Related]
28. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
29. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis.
Helliwell PS; Porter G; Taylor WJ;
Ann Rheum Dis; 2007 Jan; 66(1):113-7. PubMed ID: 16840501
[TBL] [Abstract][Full Text] [Related]
30. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.
Shankar S; Grover R; Handa R
Indian J Med Res; 2006 Dec; 124(6):689-96. PubMed ID: 17287557
[TBL] [Abstract][Full Text] [Related]
31. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.
Kane D; Stafford L; Bresnihan B; FitzGerald O
Rheumatology (Oxford); 2003 Dec; 42(12):1460-8. PubMed ID: 14523223
[TBL] [Abstract][Full Text] [Related]
32. Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.
Ji L; Li G; Xu Y; Zhou W; Zhang Z
Int J Rheum Dis; 2015 Nov; 18(8):859-65. PubMed ID: 25483781
[TBL] [Abstract][Full Text] [Related]
33. Clinical joints manifestations in patients with psoriatic arthritis on musculoskeletal ultrasound.
Zhou H; Qiu L; Sun P; Liu X; Hu X; Chen M; Wei W; Chen L; Song S; Duan T; Zhao J
Clin Rheumatol; 2022 Apr; 41(4):1211-1218. PubMed ID: 34731348
[TBL] [Abstract][Full Text] [Related]
34. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
Zhao Y; Li J; Li XX; Li C; Li L; Li ZG
Joint Bone Spine; 2009 Oct; 76(5):501-7. PubMed ID: 19289297
[TBL] [Abstract][Full Text] [Related]
35. A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicine.
de Punder YM; van Riel PL; Fransen J
J Rheumatol; 2015 Mar; 42(3):391-7. PubMed ID: 25593237
[TBL] [Abstract][Full Text] [Related]
36. Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.
Tesija-Kuna A; Grazio S; Miler M; Vukasovic I; Peric P; Vrkic N
Clin Rheumatol; 2010 May; 29(5):487-93. PubMed ID: 20069329
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis.
Haroon M; Gallagher P; FitzGerald O
Ann Rheum Dis; 2015 Jun; 74(6):1045-50. PubMed ID: 24525911
[TBL] [Abstract][Full Text] [Related]
38. Efalizumab-induced inflammatory polyarthritis: what are the implications?
Lyman J; Serebro L
South Med J; 2010 Apr; 103(4):357-60. PubMed ID: 20224509
[TBL] [Abstract][Full Text] [Related]
39. Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis.
Riccio A; Postiglione L; La Dogana P; Spanò A; Marzocchella C; Tarantino G
J Biol Regul Homeost Agents; 2008; 22(1):57-61. PubMed ID: 18394318
[TBL] [Abstract][Full Text] [Related]
40. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
